A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder

• Status: Completed
• Trial end date: 2017-11-01
• Target enrollment: 0
• Participant gender: All

Summary

A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Vanda Pharmaceuticals

Criteria

Inclusion Criteria:

• Ability and acceptance to provide written consent

• Men or women between 18-75 years

• Body Mass Index of ≥ 18 and ≤ 30 kg/m2

Exclusion Criteria:

• History (within the 12 months prior to screening) of psychiatric disorders

• Major surgery, trauma, illness or immobile for 3 or more days within the past month

• Pregnancy or recent pregnancy (within 6 weeks)

• A positive test for drugs of abuse at the screening visit

• Any other sound medical reason as determined by the clinical investigator